zip >>> 10591
sector >>> Healthcare
fullTimeEmployees >>> 8142
longBusinessSummary >>> Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis in adults, and asthma in adults and adolescents; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; and Kevzara solution for subcutaneous injection for treating rheumatoid arthritis in adults. In addition, the company offers Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer. Further, it is developing various product candidates for treating patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases, and other diseases. The company has collaboration and license agreements with Sanofi; Bayer; Teva; Mitsubishi Tanabe Pharma; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Vyriad, Inc., as well as has an agreement with the U.S. Department of Health and Human Services. It has collaborations with Zai Lab Limited; Intellia Therapeutics, Inc.; and BioNTech. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York.
city >>> Tarrytown
phone >>> 914 847 7000
state >>> NY
country >>> United States
companyOfficers >>> []
website >>> http://www.regeneron.com
maxAge >>> 1
address1 >>> 777 Old Saw Mill River Road
industry >>> Biotechnology
previousClose >>> 557.46
regularMarketOpen >>> 555.4
twoHundredDayAverage >>> 573.8556
trailingAnnualDividendYield >>> None
payoutRatio >>> 0
volume24Hr >>> None
regularMarketDayHigh >>> 575.915
navPrice >>> None
averageDailyVolume10Day >>> 794814
totalAssets >>> None
regularMarketPreviousClose >>> 557.46
fiftyDayAverage >>> 589.2621
trailingAnnualDividendRate >>> None
open >>> 555.4
toCurrency >>> None
averageVolume10days >>> 794814
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> None
exDividendDate >>> None
beta >>> 0.493311
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 551
priceHint >>> 2
currency >>> USD
trailingPE >>> 22.227127
regularMarketVolume >>> 643630
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 61075390464
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 720807
priceToSalesTrailing12Months >>> 7.0256515
dayLow >>> 551
ask >>> 578.5
ytdReturn >>> None
askSize >>> 800
volume >>> 643630
fiftyTwoWeekHigh >>> 664.64
forwardPE >>> 16.943918
fromCurrency >>> None
fiveYearAvgDividendYield >>> None
fiftyTwoWeekLow >>> 272.02
bid >>> 548.4
tradeable >>> False
dividendYield >>> None
bidSize >>> 800
dayHigh >>> 575.915
exchange >>> NMS
shortName >>> Regeneron Pharmaceuticals, Inc.
longName >>> Regeneron Pharmaceuticals, Inc.
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EDT
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -14400000
quoteType >>> EQUITY
symbol >>> REGN
messageBoardId >>> finmb_33715
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 6.842
beta3Year >>> None
profitMargins >>> 0.3432
enterpriseToEbitda >>> 19.643
52WeekChange >>> 1.0694304
morningStarRiskRating >>> None
forwardEps >>> 33.88
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 104543000
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 86.37
sharesShort >>> 1587127
sharesPercentSharesOut >>> 0.0149
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.68354
netIncomeToCommon >>> 2983500032
trailingEps >>> 25.827
lastDividendValue >>> None
SandP52WeekChange >>> 0.108078
priceToBook >>> 6.6465206
heldPercentInsiders >>> 0.23819
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1593475200
shortRatio >>> 2.56
sharesShortPreviousMonthDate >>> 1596153600
floatShares >>> 100674123
enterpriseValue >>> 59480383488
threeYearAverageReturn >>> None
lastSplitDate >>> None
lastSplitFactor >>> None
legalType >>> None
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> 3.647
dateShortInterest >>> 1598832000
pegRatio >>> 1.59
lastCapGain >>> None
shortPercentOfFloat >>> 0.0207
sharesShortPriorMonth >>> 1890090
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 555.4
logo_url >>> https://logo.clearbit.com/regeneron.com
